Image Place holder

Jasreman Dhillon, MD


Specialty: Pathology
Program: Anatomic Pathology

Call 1-888-MOFFITT
(1-888-663-3488)

or call 1-888-MOFFITT
(1-888-663-3488)

Overview

Dr. Dhillon received her medical training in India before moving to the United States. In the US she did her residency training in Pathology at Winthrop University Hospital, New York and three fellowships from MD Anderson Cancer Center in Surgical Pathology, Genitourinary (GU) Pathology and Cytopathology. Dr. Dhillon is a board-certified subspecialty trained pathologist currently working as an assistant member in the Department of Anatomic Pathology. She specializes in GU Pathology and Cytopathology.

Education & Training

Board Certification:

  • Cytopathology
  • Anatomic Pathology & Clinical Pathology

Fellowship:

  • MD Anderson Cancer Center - Genitourinary Pathology
  • MD Anderson Cancer Center - Cytopathology

Residency:

  • Postgraduate Institute of Medical Education and Research, Chandigarh - Anatomic and Clinical Pathology
  • Winthrop University Hospital/SUNY Stony Brook - Anatomic and Clinical Pathology

Medical School:

  • Government Medical College, Chandigarh - MD
Participating Trials

CLINICAL TRIAL 17753
Focal Prostate Radio-Frequency Ablation for the Treatment of Prostate Cancer
Condition: Genitourinary
Intervention:
Open

CLINICAL TRIAL 18523
A Validation Study on the Impact of Decipher® Testing on Treatment Recommendations in African-American and Non-African American Men with Prostate Cancer (VANDAAM Study)
Condition: Genitourinary
Intervention: Not Applicable
Open

CLINICAL TRIAL 18201
A Phase I Dose Escalation Study of Preoperative Stereotactic Body Radiation Therapy (SBRT) for High Risk Prostate Cancer
Condition: Genitourinary
Intervention: Not Applicable
Open

If you believe you are eligible for one of these trials or studies, please call
1-888-MOFFITT (1-888-663-3488).

Publications

  • Marshall C, Mounzer R, Hall M, Simon V, Centeno B, Dennis K, Dhillon J, Fan F, Khazai L, Klapman J, Komanduri S, Lin X, Lu D, Mehrotra S, Muthusamy VR, Nayar R, Paintal A, Rao J, Sams S, Shah J, Watson R, Rastogi A, Wani S. Suboptimal Agreement Among Cytopathologists in Diagnosis of Malignancy Based on Endoscopic Ultrasound Needle Aspirates of Solid Pancreatic Lesions: A Validation Study. Clin Gastroenterol H. 2017 Sep. Pubmedid: 28911946.
  • McCormick B, Dahmen A, Antar A, Baumgarten A, Dhillon J, Spiess PE. Rare urologic tumors. Curr Opin Urol. 2017 Jan;27(1):68-75. Pubmedid: 27798414.
  • Paranjape AN, Soundararajan R, Werden SJ, Joseph R, Taube JH, Liu H, Rodriguez-Canales J, Sphyris N, Wistuba I, Miura N, Dhillon J, Mahajan N, Mahajan K, Chang JT, Ittmann M, Maity SN, Logothetis C, Tang DG, Mani SA. Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties. Oncogene. 2016 Nov;35(46):5963-5976. Pubmedid: 26804168. Pmcid: PMC5116559.
  • Haake SM, Li J, Bai Y, Kinose F, Fang B, Welsh EA, Zent R, Dhillon J, Pow-Sang JM, Chen YA, Koomen JM, Rathmell WK, Fishman M, Haura EB. Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics. Clin Cancer Res. 2016 Nov;22(22):5605-5616. Pubmedid: 27220961. Pmcid: PMC5122466.
  • Haake SM, Brooks SA, Welsh E, Fulp WJ, Chen DT, Dhillon J, Haura E, Sexton W, Spiess PE, Pow-Sang J, Rathmell WK, Fishman M. Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities. Urol Oncol. 2016 Mar;34(3):122.e1-122.e7. Pubmedid: 26546482. Pmcid: PMC4761468.
  • Spiess PE, Dhillon J, Baumgarten AS, Johnstone PA, Giuliano AR. Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies. CA-Cancer J Clin. 2016 Jun. Pubmedid: 27314890.
  • Luchey AM, Manimala NJ, Dickinson S, Dhillon J, Agarwal G, Lockhart JL, Spiess PE, Sexton WJ, Pow-Sang JM, Gilbert SM, Poch MA. Change in Management Based on Pathologic Second Opinion Among Bladder Cancer Patients Presenting to a Comprehensive Cancer Center: Implications for Clinical Practice. Urology. 2016 Jul;93:130-134. Pubmedid: 27041469.
  • Markow M, Bui MM, Lin HY, Lloyd M, Sexton WJ, Dhillon J. Evaluation of PAX8 Expression and Its Potential Diagnostic and Prognostic Value in Renal and Extra-Renal Ewing Sarcomas/PNETs. Pathol Oncol Res. 2016 Jan;22(1):115-120. Pubmedid: 26350056.
  • Zargar-Shoshtari K, Spiess PE, Berglund AE, Sharma P, Powsang JM, Giuliano A, Magliocco AM, Dhillon J. Clinical Significance of p53 and p16(ink4a) Status in a Contemporary North American Penile Carcinoma Cohort. Clin Genitourin Cancer. 2016 Aug;14(4):346-351. Pubmedid: 26794389.
  • Kim T, Zargar-Shoshtari K, Dhillon J, Lin HY, Yue B, Fishman M, Sverrisson EF, Spiess PE, Gupta S, Poch MA, Sexton WJ. Using percentage of sarcomatoid differentiation as a prognostic factor in renal cell carcinoma. Clin Genitourin Cancer. 2015 Jun;13(3):225-230. Pubmedid: 25544725.
  • Dhillon J, Liang Y, Kamat AM, Siefker-Radtke A, Dinney CP, Czerniak B, Guo CC. Urachal carcinoma: a pathologic and clinical study of 46 cases. Hum Pathol. 2015 Dec;46(12):1808-1814. Pubmedid: 26364859. Pmcid: PMC4824311.
  • Sharma P, Dhillon J, Agarwal G, Zargar-Shoshtari K, Sexton WJ. Disparities in Interpretation of Primary Testicular Germ Cell Tumor Pathology. Am J Clin Pathol. 2015 Aug;144(2):289-294. Pubmedid: 26185314.
  • Sharma P, Dhillon J, Sexton WJ. Intratubular Germ Cell Neoplasia of the Testis, Bilateral Testicular Cancer, and Aberrant Histologies. Urol Clin North Am. 2015 Aug;42(3):277-285. Pubmedid: 26216815.
  • Zhao Y, Bui MM, Spiess PE, Dhillon J. Sclerosing PEComa of the kidney: clinicopathologic analysis of 2 cases and review of the literature. Clin Genitourin Cancer. 2014 Oct;12(5):e229-e232. Pubmedid: 25044147.
  • Dhillon J, Mohanty SK, Krishnamurthy S. Cytologic diagnosis of thyroid-like follicular carcinoma of the kidney: A case report. Diagn Cytopathol. 2014 Mar;42(3):273-277. Pubmedid: 23166108.
  • Sverrisson EF, Kim T, Espiritu PN, Sexton WJ, Pow-Sang JM, Dhillon J, Spiess PE. The merits of cytology in the workup for upper tract urothelial carcinoma - a contemporary review of a perplexing issue. Int Braz J Urol. 2014 Jul;40(4):493-498. Pubmedid: 25251966.
  • Espiritu PN, Sverrisson EF, Sexton WJ, Pow-Sang JM, Poch MA, Dhillon J, Spiess PE. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection. Urol Oncol. 2014 Jul;32(5):619-624. Pubmedid: 24495448.
  • Dhillon J, Mohanty SK, Kim T, Sexton WJ, Powsang J, Spiess PE. Spectrum of renal pathology in adult patients with congenital renal anomalies-a series from a tertiary cancer center. Ann Diagn Pathol. 2014 Feb;18(1):14-17. Pubmedid: 24321461.
  • Guo M, Khanna A, Dhillon J, Patel SJ, Feng J, Williams MD, Bell DM, Gong Y, Katz RL, Sturgis EM, Staerkel GA. Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma. Cancer Cytopathol. 2014 Feb;122(2):96-103. Pubmedid: 24339259.
  • Gallaher J, Cook LM, Gupta S, Araujo A, Dhillon J, Park JY, Scott JG, Pow-Sang J, Basanta D, Lynch CC. Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling. Clin Exp Metastas. 2014 Dec;31(8):991-999. Pubmedid: 25173680. Pmcid: PMC5399888.
  • House JC, Henderson-Jackson EB, Johnson JO, Lloyd MC, Dhillon J, Ahmad N, Hakam A, Khalbuss WE, Leon ME, Chhieng D, Zhang X, Centeno BA, Bui MM. Diagnostic digital cytopathology: Are we ready yet?. J Pathol Inform. 2013 Oct;4:28. Pubmedid: 24392242. Pmcid: PMC3869956.
  • Sircar K, Huang H, Hu L, Cogdell D, Dhillon J, Tzelepi V, Efstathiou E, Koumakpayi IH, Saad F, Luo D, Bismar TA, Aparicio A, Troncoso P, Navone N, Zhang W. Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer. Am J Pathol. 2012 Mar;180(3):895-903. Pubmedid: 22245216. Pmcid: PMC4715215.
  • Sircar K, Huang H, Hu L, Liu Y, Dhillon J, Cogdell D, Aprikian A, Efstathiou E, Navone N, Troncoso P, Zhang W. Mitosis phase enrichment with identification of mitotic centromere-associated kinesin as a therapeutic target in castration-resistant prostate cancer. PLoS One. 2012 Jun;7(2):e31259. Pubmedid: 22363599. Pmcid: PMC3281954.
  • Dhillon J, Tannir NM, Matin SF, Tamboli P, Czerniak BA, Guo CC. Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes. Hum Pathol. 2011 Jan;42(1):146-150. Pubmedid: 20971497. Pmcid: PMC4163005.
  • Dhillon J, Krishnamurthy S, Fuller GN. Papillary tumour of the pineal region: diagnosis by cytology smear. Cytopathology. 2010 Aug;21(4):267-269. Pubmedid: 19832879.
  • Dhillon J, Amin MB, Selbs E, Turi GK, Paner GP, Reuter VE. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change. Am J Surg Pathol. 2009 Jan;33(1):44-49. Pubmedid: 18941398.
  • Lue K, Emtage JB, Pariñas MA, Dhillon J, Pow-Sang J. An extramedullary plasmacytoma in the testicle: A case report and review of the literature. Can Urol Assoc J. 9(3-4):E240-E242. Pubmedid: 26085896. Pmcid: PMC4455656.
  • Pradhan D, Kaman L, Dhillon J, Mohanty SK. Mediastinal mixed germ cell tumor in an infertile male with Klinefelter syndrome:A case report and literature review. J Cancer Res Ther. 11(4):1034. Pubmedid: 26881632.